Latest news
Crinetics Pharmaceuticals (NASDAQ: CRNX) sees 1.4% stake reported by FMR LLC - Stock TitanStock Titan · Fri, 07 Aug 2026 15:05:25 GMTCrinetics Pharmaceuticals (NASDAQ: CRNX) agrees to $85 cash sale to Vertex - Stock TitanStock Titan · Mon, 03 Aug 2026 20:13:54 GMTCrinetics (Nasdaq: CRNX) agrees to $85 cash-per-share sale to Vertex - Stock TitanStock Titan · Mon, 03 Aug 2026 20:09:27 GMTCrinetics' once-daily acromegaly treatment brought in $24M in Q2 - Stock TitanStock Titan · Mon, 03 Aug 2026 20:05:00 GMT